Gerasimos V.
- Country
- Germany
- Department
- Klinik für Pneumologie, Beatmungsmedizin/Weaning, Thoraxonkologie und Schlafmedizin
Research Overview
Data & Insights
Has run more than one trial at 0 of 56 partner sites.
Specializations
Thoracic Oncology
Focus on non‑small cell lung cancer treatment strategies. Research includes HER2‑positive breast cancer therapeutic approaches.
- Platinum‑based chemotherapy combined with immunotherapy
- Antibody‑drug conjugates in neoadjuvant settings
- Targeted HER2 inhibition
- Biomarker‑driven patient selection
Efforts aim to improve disease‑free survival across advanced thoracic malignancies.
Hematologic Malignancies
Investigation of acute myeloid leukemia therapeutic regimens. Studies also address myelodysplastic syndrome with excess blasts.
- FLT3‑targeted kinase inhibitors
- Venetoclax‑based combination therapy
- Maintenance strategies post‑induction
- Risk‑adapted dosing schedules
Aim is to extend event‑free survival and achieve deeper remissions.
Cardiovascular & Cerebrovascular Medicine
Clinical work includes acute ischemic stroke intervention research. Additional focus on atrial fibrillation–related stroke prevention and cancer‑associated thrombosis management.
- Anticoagulant strategies for stroke risk reduction
- Oral factor XI inhibitors evaluation
- Early rhythm‑control in post‑stroke atrial fibrillation
- Prophylactic anticoagulation in oncology patients
Projects target reduction of recurrent vascular events.
Respiratory Medicine & Sleep
Specialization in mechanical ventilation weaning protocols. Research also covers obstructive sleep apnea management.
- Weaning algorithm optimization
- Non‑invasive ventilation outcomes
- Sleep‑disordered breathing diagnostics
- Impact of ventilation on pulmonary recovery
Clinical pathways aim to shorten intensive care stays and improve sleep quality.
Gynecologic Oncology
Focus on high‑grade ovarian cancer treatment combinations. Includes studies of peritoneal and fallopian tube carcinomas.
- Platinum‑paclitaxel chemotherapy with targeted agents
- PARP inhibitor maintenance therapy
- Neoadjuvant strategies for advanced disease
- Biomarker‑guided therapeutic decisions
Goal is to increase progression‑free survival in advanced gynecologic malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.